MediScan Co., Ltd.

Shaping the Future
of
Medical Research

Medical Research

Technology for Life

Scroll

Vision

Revolutionizing testing standards by combining analytical technology with cutting-edge AI.

We are pursuing testing technologies that anyone can undergo at ease and aiming to achieve medical care that can detect diseases earlier and more reliably.

Mission

Non-invasive, accurate, and easy-to-take testing.

Our mission is to reduce the physical and psychological burdens that are associated with standard cancer testing as well as expand the accessibility for testing through research and development of non-invasive breath-based cancer screening technology.

Business

Making early cancer detection more accessible and gentle.

MediScan is engaged in research and development of non-invasive testing technology that enable early detection various cancers, initially starting with breast cancer, through advanced analysis of the components of VOCs (volatile organic compounds) present in exhaled breath.

Non-invasive, painless detection
Easy testing with
a single breath
Highly accurate detection of biomarkers

Business

Team

Expert Teams × Global Collaboration
Research and development system that creates
the future of medical care

Koichiro Yoshino

President & CEO (Chief Executive Officer)

After graduating from Iwate Medical University School of Medicine, he completed his residency at Toda Central General Hospital, followed by gaining clinical experience at Tokyo Medical University Hospital and Ibaraki Medical Center. He later on earned a Ph.D. in the field of oncology and then founded MediScan Co., Ltd. (formerly YOSHINO MEDICAL).
Motivated by the cancer diagnoses of both his parents, he expanded his activities to include reasearch on early cancer detection and medical device development.

facebook

Team Members

Masato Takaishi

Executive Vice President & COO (Chief Operating Officer)

Kotaro Shimizu

CAO (Chief Academic Officer)

Taku Kadowaki

CFO (Chief Financial Officer)

Daisuke Tanida

CSO (Chief Strategy Officer)

Collaborator In Israel

Moshe Feldman

VOCs Medical Ltd.
CEO Chairman

Dr.Gal

Technion-Israel Institute of Technology
Specialization / AI & Algorithm Development

Daniel Moskovich

Research Team Member (Israel)
Specialization / AI & Algorithm

Dr.Igal

Tel Aviv University
Specialization / Volatile Organic Compounds & GCMS

Prof.Amie

Ariel University
Specialization / Analytical Instrument Development

Collaborator

Sadako Akashi

Tokyo Women's Medical University
Specialization / Breast & Gynecological Surgery

MC EVATECH Co., Ltd.

Breath Analysis Machine for Clinical Trials
HP / https://www.mcet.co.jp/

Redefining Cancer Detection